Johnson & Johnson (Pty) Ltd has entered into a definite agreement to buy V-Wave Ltd. in a deal valued at potentially $1.7bn, which marks its second major deal in medtech this year, following the $13.1bn Shockwave Medical acquisition.
J&J Acquires Heart Failure Implant Company V-Wave For Up To $1.7Bn, Expanding Its Medtech Portfolio In Cardiology
J&J buys heart failure implant company V-Wave, whose Ventura Interatrial Shunt could be the first device of its kind aimed to reach the roughly 800,000 patients in the US who experience heart failure and reduce ejection fraction every year.
